Monday, August 29, 2011

FDA to Vote on Zelrix Migraine Patch Approval


New to Somebody Heal Me? Subscribe to the Somebody Heal Me feed:
Subscribe in a reader or subscribe by e-mail. Follow me on Twitter @somebodyhealme.

The Philadelphia Business Journal reports that the FDA will vote on approval of NuPathe Pharmaceuticals' electronic migraine patch called Zelrix on Monday, August 29. The Zelrix patch will provide a new delivery method for existing migraine treatment medication sumatriptan.

This spring I (and other migraine advocates) had the chance to work with NuPathe on a project to educate patients about migraine-related nausea (MigraineNausea.com). I can attest that they are an outstanding small company committed to helping provide migraine patients with options that truly meet their needs. Hopefully for both their sake and ours, the FDA will approve this fascinating new option for helping migraineurs treat their attacks without relying on their often problematic stomachs to process a medication.

To learn more about the Zelrix patch, visit these previous Somebody Heal Me posts about it and related issues:

Why Are Pills Hard for Migraineurs to Use?
Migraine Medications 101: Triptans
Details of Sumatriptan Migraine Patch to be Released at IHS Meeting
Zelrix Transmits Sumatriptan Through Skin Patch


Subscribe to the Somebody Heal Me feed: Subscribe in a reader or subscribe by e-mail. Follow me on Twitter @somebodyhealme.

Photo Sharing and Video Hosting at Photobucket Content by Diana E. Lee.

DISCLAIMER: Nothing on this site constitutes medical or legal advice. I am a patient who is engaged and educated and enjoys sharing my experiences and news about migraines, pain and depression. Please consult your own health care providers for advice on your unique situation.